Opportunity

Centers for Medicare & Medicaid Services #260093J

CMS Seeks Professional Services for Medicare Part D Patient Safety Quality Analysis

Buyer

Health and Human Services Department, Centers for Medicare & Medicaid Services, Office of the Secretary

Posted

June 04, 2026

Identifier

260093J

NAICS

541690

This opportunity is issued by the Centers for Medicare & Medicaid Services (CMS), under the Department of Health and Human Services, seeking professional services to support Medicare Part D Patient Safety Quality Analysis. - Government Buyer: - Department of Health and Human Services (HHS) - Centers for Medicare & Medicaid Services (CMS) - Contracting Office: 7500-7530-00500, Division: MSCG - DMMC, Center: CM - MDBCDDG - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Products/Services Requested: - Professional services to assist in developing and calculating performance and quality measures for Medicare Part D sponsors - Support for accountability in care through Part D Patient Safety measures - Addressing opioid overutilization via the Opioid Management Strategy (OMS) - Analysis of patient safety, quality, and medication safety metrics - Evaluation of the impact of current and future Part D policies on beneficiary healthcare utilization and outcomes - Unique/Notable Requirements: - Focus on healthcare quality analysis and improvement - Emphasis on opioid management and patient safety - No hardware, software, or specific product part numbers requested - Anticipated as a sole source, time and materials contract via GSA MAS Order - Estimated contract value between $5M and $10M over five years

Description

This contract aims to assist CMS in developing and calculating performance and quality measures for Medicare Part D sponsors. The contractor will support CMS in improving accountability for care through Part D Patient Safety measures and help address opioid overutilization via the Opioid Management Strategy (OMS). Tasks include analysis of patient safety, quality, and medication safety metrics, as well as evaluating the impact of current and future Part D policies on beneficiary healthcare utilization and outcomes.

View original listing